Literature DB >> 2846422

Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.

E S Wargotz1, S G Silverberg.   

Abstract

Fifty-three cases of mammary carcinoma originally diagnosed as medullary carcinoma (MC) or infiltrating duct carcinoma (IDC) with medullary features were reviewed and reclassified using the strictly defined histologic criteria applied a decade ago by Ridolfi et al. Our study interval (1961 to 1982) allowed for a minimum follow-up of 5 years for each patient, with a mean follow-up period of 7.2 years. When reclassified, 24 tumors fulfilled the criteria for MC, 16 tumors were determined to be atypical MC, and ten tumors were found to be IDC; the observed 5-year survival rates were 95%, 80%, and 70%, respectively. These findings confirmed those of other investigators, that when specific criteria are applied, MC proves to be a form of mammary carcinoma with a favorable prognosis. However, we also found that when tumors were excluded from the MC category solely on the basis of in situ carcinoma, focal marginal infiltration, or a sparse mononuclear infiltrate, the survival rate of these patients was similar to that of patients in the medullary category. Thus, we propose that one of these criteria alone should not suffice to exclude the diagnosis of MC. On the other hand, tumors with two or more of these atypical features, or with extensive marginal infiltration, no mononuclear cellular infiltrate, and/or less than 75% syncytial growth, should be classified as IDC with medullary features. Typical MC with bland nuclei or a focal microglandular growth pattern only were not observed in this series; however, these findings should probably also cause a tumor to be classified in the IDC category. By dividing our cases into two rather than three groups, we found a statistically significant difference between the survival rates of 94% and 64% for MC (34 tumors) and IDC (14 tumors), respectively. Although the latter figure probably exceeds the survival rate for IDC without medullary features, the difference does not appear great enough to warrant a separate diagnostic category.

Entities:  

Mesh:

Year:  1988        PMID: 2846422     DOI: 10.1016/s0046-8177(88)80290-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

1.  HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.

Authors:  M Feinmesser; A Sulkes; S Morgenstern; J Sulkes; S Stern; E Okon
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  Atypical medullary carcinoma of the breast.

Authors:  Kenichi Sakurai; Sadanori Matsuo; Katsuhisa Enomoto; Sadao Amano; Motomi Shiono
Journal:  J Med Ultrason (2001)       Date:  2009-08-27       Impact factor: 1.314

3.  Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.

Authors:  Hajime Kuroda; Jun-ichi Tamaru; Goi Sakamoto; Kiyoshi Ohnisi; Shinji Itoyama
Journal:  Virchows Arch       Date:  2004-11-30       Impact factor: 4.064

4.  High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast.

Authors:  H Tanaka; M Hori; T Ohki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 5.  Medullary cancer of the breast revisited.

Authors:  E R Fisher; J P Kenny; R Sass; N V Dimitrov; R H Siderits; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

6.  8p deletion is strongly linked to poor prognosis in breast cancer.

Authors:  P Lebok; A Mittenzwei; M Kluth; C Özden; B Taskin; K Hussein; K Möller; A Hartmann; A Lebeau; I Witzel; S Mahner; L Wölber; F Jänicke; S Geist; P Paluchowski; C Wilke; U Heilenkötter; R Simon; G Sauter; L Terracciano; R Krech; A von der Assen; V Müller; E Burandt
Journal:  Cancer Biol Ther       Date:  2015-05-11       Impact factor: 4.742

7.  The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.

Authors:  M H Hansen; H Nielsen; H J Ditzel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

8.  Vimentin expression in 98 breast cancers with medullary features and its prognostic significance.

Authors:  S Holck; L Pedersen; T Schiødt; K Zedeler; H Mouridsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast.

Authors:  Kok Haw Jonathan Lim; Premasiri Upali Telisinghe; Muhd Syafiq Abdullah; Ranjan Ramasamy
Journal:  Cancer Immun       Date:  2010-01-22

10.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.